Showing results (151-160 of 347) with videos related to

Sort By:
Pageof 35
International Journal of Oncology|May 11, 2006
Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteinsGunhild Keller, Andrew V Schally, Attila Nagy, et al.
Targeted Oncology|October 9, 2014
Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC)C W Kwok, O Treeck, S Buchholz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2014
FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14Tatyana Novoyatleva, Amna Sajjad, Denys Pogoryelov, et al.
Human Reproduction (Oxford, England)|September 9, 2010
Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriagesArnd Honig, Joerg B Engel, Sabine E Segerer, et al.
Reproductive Biomedicine Online|November 7, 2002
Clomiphene-induced LH surges and cetrorelixJörg B Engel, Ricardo E Felberbaum, Wiebke Eilers, et al.
Veterinary Microbiology|April 7, 2004
Effect of acidified feed on susceptibility of broiler chickens to intestinal infection by Campylobacter and SalmonellaL Heres, B Engel, H A P Urlings, et al.
Cancer|July 28, 2005
Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1Jorg B Engel, Andrew V Schally, Gabor Halmos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215Jörg B Engel, Gunhild Keller, Andrew V Schally, et al.
Cancer|October 8, 2005
Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomasGunhild Keller, Andrew V Schally, Attila Nagy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2005
Experimental therapy of human endometrial cancers with a targeted cytotoxic bombesin analog AN-215: low induction of multidrug resistance proteinsJörg B Engel, Andrew V Schally, Gabor Halmos, et al.
Pageof 35